Allozyne, Inc. Conducts Round of Employee "Furloughs"
3/15/2013 12:17:09 PM
More...
|
Poniard Pharmaceuticals, Inc. (PARD) Announces Shareholders Approve Merger With Allozyne, Inc.
11/22/2011 7:39:44 AM
More...
|
Allozyne, Inc. Announces Positive Results from Phase 1B Trial of AZ01
10/19/2011 7:01:59 AM
More...
|
Poniard Pharmaceuticals, Inc. (PARD) Announces Effectiveness of Form S-4 Registration Statement for the Proposed Merger with Allozyne, Inc.
10/10/2011 9:16:49 AM
More...
|
Poniard Pharmaceuticals, Inc. (PARD) Announces Filing of Form S-4 Registration Statement Related to Proposed Merger With Allozyne, Inc.
7/26/2011 9:01:39 AM
More...
|
Allozyne, Inc. Acquires Poniard Pharmaceuticals, Inc. (PARD), Finds Backdoor Route to NASDAQ
6/23/2011 8:21:49 AM
More...
|
Allozyne, Inc. Announces Completion of Phase IA Trial by AZ01, a Long Lasting Interferon B for Treatment of Relapsing Remitting Multiple Sclerosis
1/11/2011 9:31:01 AM
More...
|
Allozyne, Inc. Announces Completion of Phase Ia Trial By Az01, a Long Lasting Interferon ? for Treatment of Relapsing Remitting Multiple Sclerosis
1/10/2011 12:08:00 PM
More...
|
Allozyne, Inc. Announces Positive Proof of Concept Data For Az17, a Bispecific Th17 Antagonist for Treatment of Autoimmune Diseases
11/16/2010 12:55:50 PM
More...
|
Allozyne, Inc. Inks Sigma-Aldrich Corporation (SIAL) Deal
8/12/2010 8:09:34 AM
More...
|
|